Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
8.71 USD | +3.69% | -7.64% | -28.84% |
Mar. 28 | Transcript : Pulse Biosciences, Inc., Q4 2023 Earnings Call, Mar 28, 2024 | |
Mar. 08 | Sector Update: Health Care Stocks Ease Late Afternoon | MT |
Business Summary
Number of employees: 61
Sales per Business
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Systems
80.0
%
| 1 | 83.9 % | 1 | 80.0 % | -52.90% |
Cycle Units
20.0
%
| 0 | 16.1 % | 0 | 20.0 % | -38.86% |
Sales per region
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
North America
73.9
%
| 1 | 83.4 % | 1 | 73.9 % | -56.26% |
Rest of World
26.1
%
| 0 | 16.6 % | 0 | 26.1 % | -22.46% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Kevin Danahy
CEO | Chief Executive Officer | 54 | 22-02-13 |
Chief Tech/Sci/R&D Officer | - | 23-05-02 | |
Chief Tech/Sci/R&D Officer | - | - | |
Edison Manuel
COO | Chief Operating Officer | - | 17-03-31 |
David Danitz
CTO | Chief Tech/Sci/R&D Officer | - | 15-10-31 |
Darrin R. Uecker
CTO | Chief Tech/Sci/R&D Officer | 59 | 15-09-14 |
Corporate Officer/Principal | 63 | 19-03-17 | |
William Knape
LAW | General Counsel | - | 18-05-10 |
Patty Perla
HRO | Human Resources Officer | - | 20-02-29 |
Joseph Talarico
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Duggan
CHM | Chairman | 79 | 17-11-01 |
Director/Board Member | 46 | 17-11-01 | |
Darrin R. Uecker
CTO | Chief Tech/Sci/R&D Officer | 59 | 15-09-14 |
Mahkam Zanganeh
BRD | Director/Board Member | 52 | 17-02-09 |
Director/Board Member | 63 | 14-12-31 | |
Shelley D. Spray
BRD | Director/Board Member | 59 | 21-11-23 |
Director/Board Member | 57 | 20-08-05 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 55,080,527 | 16,218,084 ( 29.44 %) | 0 | 29.44 % |
Company contact information
Pulse Biosciences, Inc.
3957 Point Eden Way
94545, Hayward
+510 906 4600
http://www.pulsebiosciences.comSector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
-28.84% | 480M | |
+9.50% | 222B | |
+7.95% | 185B | |
+18.30% | 141B | |
+18.47% | 100B | |
+7.83% | 68.36B | |
+25.32% | 57.52B | |
-3.15% | 46.84B | |
+4.66% | 42.64B | |
+17.58% | 41.4B |
- Stock
- Equities
- Stock Pulse Biosciences, Inc. - Nasdaq
- Company Pulse Biosciences, Inc.